A comprehensive view of Centers for Medicare & Medicaid Services (CMS). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Commentary: Cost of expanding US Medicare coverage to pay for costly obesity drugs could be catastrophic, say economists; once-weekly injections of Novo Nordisk's Wegovy costs US$13,000/year in US, and Eli Lilly's Mounjaro retails at US$1,540/month supply

Medicare to expand continuous glucose monitor coverage to a larger group of patients staring in April, which could double the market for the devices; about 25% of people with Type 2 diabetes currently use a CGM

Quest Diagnostics introduces new obstetrics laboratory test panel to screen eligible pregnant women for hepatitis C; in 2021 fewer than 41% of pregnant women were screened for HCV, with screening rates dropping 25% to 35% for women with Medicaid

GlobalData forecasts US pharmaceutical sales of prescription/nonprescription drugs to hit US$624B in 2023, but expects few pharmaceutical companies to be left unaffected by Medicare’s planned negotiation on US drug prices, which go into full effect 2026

Moody's: US drug pricing reform in Inflation Reduction Act may have credit-lowering effect on industry; it’s unclear which drugs costs will get negotiated, but potential candidates include drugs from Bristol Myers, Pfizer, Eli Lilly, AbbVie, J&J, Gilead

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count